Keywords: MRD، حداقل بیماری باقی مانده; HCC, hepatocellular carcinoma; IR, immune repertoire; CDR, complementarity-determining regions; TCRs, T cell receptors; BCRs, B cell receptors; MRD, minimal residual disease; HTS, high-throughput sequencing; IR-SEQ, immune repertoire sequencing; TILs, tum
مقالات ISI MRD، حداقل بیماری باقی مانده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MRD، حداقل بیماری باقی مانده; Circulating tumor DNA; Liquid biopsy; Intra-tumor heterogeneity; Disease monitoring; Molecular resistance; Early detectionctDNA, circulating tumor DNA; MPS, massive parallel sequencing; MRD, minimal residual disease; NGS, Next Generation Sequencing; PCR,
Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity
Keywords: MRD، حداقل بیماری باقی مانده; SCT, stem cell transplantation; CTLA-4, cytotoxic T lymphocyte-associated antigen-4; GVHD, graft-vs.-host disease; GVM, graft-vs.-malignancy; GVL, graft-vs.-leukemia effects; DLI, donor lymphocyte infusion; MRD, minimal residual disease; irAEs, immune-rel
Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course
Keywords: MRD، حداقل بیماری باقی مانده; MRD, minimal residual disease; AS-qPCR, allele-specific quantitative polymerase chain reaction; HSCT, hematopoietic stem cell transplantation; AML, acute myeloid leukemia; BM, bone marrow; ARMS, amplification refractory mutation system; MAMA, mismatch amp
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma
Keywords: MRD، حداقل بیماری باقی مانده; AS-PCR, allele-specific polymerase chain reaction; CNS, central nervous system; CSF, cerebrospinal fluid; CT, computed tomography; MRD, minimal residual disease; MRI, magnetic resonance imaging; M1, first mutation; M2, second mutation; PCR, polymerase cha
The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
Keywords: MRD، حداقل بیماری باقی مانده; CML, chronic myeloid leukemia; ALL, acute lymphatic leukemia; IM, imatinib mesylate; BM, bone marrow; NI, nilotinib; DA, dasatinib; MRD, minimal residual disease; WT1, Wilms’ tumor 1; HSC, hematopoietic stem cell; HPC, hematopoietic progenitor cell; ECM,
Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia
Keywords: MRD، حداقل بیماری باقی مانده; NPM1, nucleophosmin; FRET, fluorescence resonance energy transfer; MRD, minimal residual disease; AML, acute myeloid leukaemiaNPM1 mutation; Real-time PCR; MRD; LightCycler
Minimal residual disease in hypopigmented mycosis fungoides
Keywords: MRD، حداقل بیماری باقی مانده; PCR, polymerase chain reaction; MF, mycosis fungoides; MRD, minimal residual disease; TCR, T-cell receptor
Detection and monitoring of minimal residual disease by quantitative real-time PCR
Keywords: MRD، حداقل بیماری باقی مانده; MRD, minimal residual disease; CML, chronic myeloid leukemia; AML, acute myeloid leukemia; NHL, non-Hodgkin lymphoma; FL, follicular lymphoma; MCL, mantle cell lymphoma; alloBSCT, allogeneic blood stem cell transplantation; autoBSCT, autologous blood stem